Immunophenotypic characterization of Epstein-Barr virus-associated gastric carcinoma: Massive infiltration by proliferating CD8+ T-lymphocytes

Laboratory Investigation

Volumn 75, Issue 1, 1996, Pages 67-76

  Saiki, Yuriko ^a   Ohtani, Haruo ^a   Naito, Yoshitaka ^a   Miyazawa, Masaaki ^a   Nagura, Hiroshi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD8 ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ARTICLE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FROZEN SECTION; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH CARCINOMA; T LYMPHOCYTE; VIRUS DETECTION;

ANTIGENS, CD; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL COUNT; CELL DIVISION; FLOW CYTOMETRY; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; MICROSCOPY, IMMUNOELECTRON; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR VIRUS INFECTIONS;

EID: 0029940397     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Berg NN and Ostergaard HL (1995). Characterization of intercellular adhesion molecule-1 (ICAM-1)-augmented degranulation by cytotoxic T cells: ICAM-1 and anti-CD3 must be co-localized for optimal adhesion and stimulation. J Immunol 155:1694-1702.
2. Burke AP, Yen TS, Shekitka KM, and Sobin LH (1990). Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 3:377-380.
3. Busson P, Zhang Q, Guillon JM, Gregory CD, Young LS, Clausse B, Lipinski M, Rickinson AB, and Tursz T (1992). Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr virus-positive nasopharyngeal carcinoma cells. Int J Cancer 50:863-867.
4. Fahraeus R, Rymo L, Rhim JS, and Klein G (1990). Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature 345:447-449.
5. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, and Osato T (1994). Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 91:9131-9135.
6. Janeway CA Jr and Bottomly K (1994). Signals and signs for lymphocyte responses. Cell 76:275-285.
7. Japanese Research Society of Gastric Cancer, editor (1995). Japanese classification of gastric carcinoma, 1st English ed. Tokyo: Kanehara & Company, 38-65.
8. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, and Golstein P (1994). Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528-530.
9. Kehrl JH (1991). Transforming growth factor-beta: An important mediator of immunoregulation. Int J Cell Cloning 9:438-450.
10. Khanna R, Burrows SR, and Moss DJ (1995). Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev 59:387-405.
11. King LB and Ashwell JD (1993). Signaling for death of lymphoid cells. Curr Opin Immunol 5:368-373.
12. Manyak CL, Tse H, Fischer P, Coker L, Sigal NH, and Koo GC (1988). Regulation of class II MHC molecules on human endothelial cells: Effects of IFN and dexamethasone. J Immunol 140:3817-3821.
13. Masson D and Tschopp J (1985). Isolation of a lytic, poreforming protein (perforin) from cytolytic T-lymphocytes. J Biol Chem 260:9069-9072.
14. Mizoi T, Ohtani H, Suzuki Y, Shibata Ki, Matsuno S, and Nagura H (1995). Intercellular adhesion molecule-1 expression by macrophages in human gastrointestinal carcinoma: Possible role as host immune/inflammatory reaction. Pathol Int 45:565-572.
15. Moller P, Henne C, Leithauser F, Eichelmann A, Schmidt A, Bruderlein S, Dhein J, and Krammer PH (1993). Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B-cell lymphomas. Blood 81:2067-2075.
16. Murray RJ, Kurilla MG, Griffin HM, Brooks JM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E, et al (1990). Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. Proc Natl Acad Sci USA 87:2906-2910.
17. Nakamura S, Ueki T, Yao T, Ueyama T, and Tsuneyoshi M (1994). Epstein-Barr virus in gastric carcinoma with lymphoid stroma: Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. Cancer 73:2239-2249.
18. Oda K, Tamaru J, Takenouchi T, Mikata A, Nunomura M, Saitoh N, Sarashina H, and Nakajima N (1993). Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am J Pathol 143:1063-1071.
19. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li WM, Richards S, Dhein J, Trauth BC, et al (1992). Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: Sequence identity with the Fas antigen. J Biol Chem 267:10709-10715.
20. Ohtani H, Kuroiwa A, Obinata M, Ooshima A, and Nagura H (1992). Identification of type I collagen-producing cells in human gastrointestinal carcinomas by non-radioactive in situ hybridization and immunoelectron microscopy. J Histochem Cytochem 40:1139-1146.
21. Pfizenmaier K, Scheurich P, Schluter C, and Kronke M (1987). Tumor necrosis factor enhances HLA-A, B,C and HLA-DR gene expression in human tumor cells. J Immunol 138:975-980.
22. Rosa MD, Gottlieb E, Lerner MR, and Steitz JA (1981). Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids Val and Vall. Mol Cell Biol 1:785-796.
23. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, and Weiss LM (1991). Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration: Lymphoepithelioma-like carcinoma. Am J Pathol 139:469-474.
24. Shibata D and Weiss LM (1992). Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140:769-774.
25. Shinkai Y, Takio K, and Okumura K (1988). Homology of perforin to the ninth component of complement (C9). Nature 334:525-527.
26. Springer TA (1990). Adhesion receptors of the immune system. Nature 346:425-434.
27. + T cell-mediated cytotoxicity. J Immunol 152:1127-1133.
28. Suzuki Y, Ohtani H, Mizoi T, Takeha S, Shiiba Ki, Matsuno S, and Nagura H (1995). Cell adhesion molecule expression by vascular endothelial cells as an immune/inflammatory reaction in human colon carcinoma. Jpn J Cancer Res 86:585-593.
29. Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, and Sato E (1993). Epstein-Barr virus in gastric carcinoma. Am J Pathol 143:1250-1254.
30. Urban JL and Schreiber H (1992). Tumor antigens. Annu Rev Immunol 10:617-644.
31. + macrophages in antitumor cytotoxicity. Lab Invest 67:166-174.
32. Zhang Q, Brooks L, Busson P, Wang F, Charron D, Kieff E, Rickinson AB, and Tursz T (1994). Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line. Eur J Immunol 24:1467-1470.